bpc 157 and gallbladder Surgery - Dr. Michael P. Choi, DO Glucagon-like peptide-2 promotes gallbladder refilling

The composition of the present invention should preferably have a unit dosage form containing the pharmacologically active BPC peptide salt of the invention and, if necessary, together with further additives such as the abovementioned water-soluble protein

Doses Per Vial Vial duration varies by dose escalation phase: 3mg vial: At 0.25mg/week = 12 weeks At 0.5mg/week = 6 weeks At 1mg/week = 3 weeks At 2.4mg/week = 1.25 weeks 5mg vial: At 0.25mg/week = 20 weeks At 0.5mg/week = 10 weeks At 1mg/week = 5 weeks At 1.7mg/week = ~3 weeks At 2.4mg/week = ~2 weeks A 5mg vial can cover the entire first 4 months of a slow escalation protocol starting at 0.25mg

Common symptoms include: Fatigue and weakness One of the earliest and most common complaints Pale or yellowish skin Due to reduced red blood cell production Shortness of breath From anemia reducing oxygen-carrying capacity Numbness or tingling in hands and feet A sign of nerve damage Balance problems and difficulty walking Neurological manifestation of deficiency Memory problems or brain fog Cognitive effects of low B12 Mood changes, depression, or irritability Sore, red, or swollen tongue (glossitis) Mouth ulcers Constipation or diarrhea Neurological symptoms numbness, balance issues, cognitive changes can become permanent if deficiency is not treated promptly

Decreasing overall body fat can lead to improved metabolic health, including better blood pressure, cholesterol levels, and blood sugar control

Uncertain Effectiveness : Promising animal data do not prove reliable human benefit, and limited clinical evidence prevents firm conclusions about recovery, pain, or tissue repair outcomes